Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Buculei Porosnicu (Iasi, Romania), L. Trofor (Iasi, Romania), C. Vicol (Iasi, Romania), I. Grosu (Iasi, Romania), A. Tifrea (Iasi, Romania), C. Vardavas (Athens, Greece), P. Behrakis (Athens, Greece), A. Trofor ( Iasi, Romania). “Lung age” – a motivational smoking cessation tool in smokers with chronic obstructive pulmonary disease. 1234

Member's Comments

No comment yet.

Related content which might interest you: Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006 Smoking cessation in patients with respiratory diseases Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006 COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Does chronic obstructive pulmonary disease (COPD) impact on women smoking cessation approach? Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018 Evidence for harm reduction in diseased smokers Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited Year: 2007 Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Introductory lecture: Nicotine addiction treatment in COPD patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007 Recommendations for smoking cessation treatment in respiratory patients Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007 Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006 Efficacy of confronting smokers with airflow limitation for smoking cessation Source: Eur Respir J 2009; 33: 754-762 Year: 2009 Overview of smoking-related disease Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Smoking cessation program as tool for early diagnosis of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 392s Year: 2006 Airway inflammation persists after smoking cessation in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Source: Eur Respir J 2007; 30: 467-471 Year: 2007 Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Fully financed smoking cessation for patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020 Success of smoking cessation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005 Smoking cessation effectiveness in smokers with obstructive respiratory disease Source: Annual Congress 2011 - Smoking cessation science Year: 2011 National epidemiological study of smoking cessation in danish patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020